Connect with licensed Delaware telehealth providers offering semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro and Zepbound. Delivered to your door in 2-3 days. Starting at $75/mo.
Find GLP-1 ProvidersSkip the clinic. Complete a quick assessment, get approved by a licensed Delaware physician, and have your prescription delivered.
Order My Shots — from $75/moThree simple steps to get GLP-1 medication delivered to your door
Answer a few quick questions about your health and weight loss goals. Takes less than 5 minutes.
A licensed Delaware physician reviews your case and prescribes the right GLP-1 protocol within 24 hours.
Your GLP-1 medication arrives at your Bowers address within 2-3 business days with free discreet shipping.
Choose the GLP-1 option that fits your goals and budget
Once-weekly semaglutide injection shots. Compounded by licensed pharmacies, same active ingredient as Ozempic and Wegovy. Ships with all needles and supplies.
Once-weekly tirzepatide injection shots — the most effective GLP-1 for weight loss. Same molecule as Mounjaro and Zepbound at a fraction of the brand cost.
Brand-name semaglutide shots in pre-filled pens. FDA-approved, insurance-covered for many patients. Ozempic for diabetes, Wegovy for chronic weight management.
Brand-name tirzepatide shots. The most effective GLP-1 medication available — up to 22.5% body weight loss in clinical trials. Pre-filled pens ship with Lilly savings card.
Clinical outcomes from GLP-1 patients at 12 months
Multiple payment and savings options available in Bowers
Many commercial insurance plans cover Ozempic, Wegovy, Mounjaro, and Zepbound injection shots with prior authorization. Our team handles the paperwork.
GLP-1 injection shots are HSA and FSA eligible. Pay with pre-tax dollars to save 20-35% depending on your tax bracket.
Compounded GLP-1 shots are the most affordable option — same active ingredients as brand-name at 75-85% less cost. Starting at $75/month for semaglutide shots.
Every GLP-1 shot order includes all injection supplies: ultra-thin 29G needles, syringes, alcohol wipes, and sharps container. Nothing extra to buy.
Novo Nordisk and Eli Lilly offer injection shot savings cards that can dramatically reduce brand-name costs for commercially insured patients.
Real patients, real transformations with GLP-1 medication
Everything you need to know about GLP-1 medication in Bowers
Bowers residents now have direct access to the full spectrum of GLP-1 weight loss medications through licensed Delaware telehealth providers. With a population of approximately 270 residents and an adult obesity rate of 42.8%, Bowers is part of a nationwide shift toward accessible, evidence-based weight management. GLP-1 medications — including semaglutide, tirzepatide, Ozempic, Wegovy, Mounjaro, and Zepbound — are now available to qualifying adults throughout the Bowers metro area with no in-person visits required.
The two leading GLP-1 classes are semaglutide (marketed as Ozempic and Wegovy) and tirzepatide (marketed as Mounjaro and Zepbound). Semaglutide activates one gut hormone receptor and produces 15-17% average body weight loss over 68 weeks. Tirzepatide activates two receptors (GLP-1 and GIP), producing up to 22.5% average weight loss at 72 weeks — the most powerful GLP-1 therapy approved today. Your Bowers provider will help you choose based on your health profile, weight loss goals, and budget.
Bowers patients can choose between brand-name GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) at $900-$1,350/month and compounded alternatives starting at $75/month for semaglutide and $149/month for tirzepatide. Compounded versions are prepared by 503A/503B licensed compounding pharmacies regulated by the Delaware State Board of Pharmacy and the FDA, and contain the same active pharmaceutical ingredients as brand-name products. Compounding provides Bowers patients with a cash-pay option during shortages and for those without insurance coverage.
To qualify for GLP-1 weight loss medication in Bowers, patients generally need a BMI of 30 or higher (obesity), or a BMI of 27 or higher (overweight) with at least one weight-related comorbidity such as type 2 diabetes, hypertension, high cholesterol, or obstructive sleep apnea. Your Bowers provider will evaluate your medical history, current medications, and weight loss goals during the online assessment to determine eligibility and match you with the appropriate GLP-1 medication and starting dose.
Insurance coverage for GLP-1 weight loss medication in Delaware varies significantly by plan. Many Blue Cross Blue Shield, UnitedHealthcare, Aetna, and Cigna plans cover Ozempic and Mounjaro for diabetic patients and Wegovy or Zepbound for weight management with prior authorization. Medicare Part D generally covers Ozempic and Mounjaro for diabetes but not Wegovy or Zepbound for weight loss. Our Bowers team can verify your benefits and submit prior authorization requests on your behalf to maximize coverage.
Common side effects of GLP-1 medications include nausea, diarrhea, decreased appetite, vomiting, constipation, and mild injection-site reactions — most resolve within the first 4 weeks as your body adjusts. Serious but rare risks include pancreatitis, gallbladder issues, and thyroid concerns. GLP-1 medications should not be used by patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Your Bowers physician will discuss the complete safety profile and start you on a low dose that titrates up gradually.
Starting GLP-1 weight loss treatment in Bowers takes just minutes. Complete a free 5-minute online assessment, undergo a virtual consultation with a licensed Delaware physician, and receive your prescription — all within 24 hours. Medication ships directly to your Bowers home in 2-3 business days via temperature-controlled packaging with all supplies (needles, syringes, alcohol wipes) included. No in-person visits, no insurance hassles, no waiting rooms — just a seamless path to proven weight loss results.
Telehealth available across Delaware and surrounding regions
GLP-1 telehealth available throughout Delaware
Join 470,000+ patients who chose telehealth GLP-1 treatment. Your licensed Delaware physician is ready to review your assessment within 24 hours.
Order My Shots — from $75/mo